Walgreens Boots Alliance(US:WBA) ZACKS·2025-06-23 14:15Core Insights - Walgreens Boots Alliance (WBA) is expected to report quarterly earnings of $0.34 per share, a decline of 46% year-over-year, with revenues forecasted at $36.66 billion, reflecting a 0.9% increase compared to the previous year [1] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating analysts have reevaluated their initial projections [1][2] Revenue Estimates - Analysts predict 'Revenues- U.S. Retail Pharmacy' to be $28.76 billion, showing a year-over-year change of +0.9% [4] - 'Revenues- U.S. Healthcare' is expected to reach $2.17 billion, indicating a +2.3% change year-over-year [4] - 'Revenues- International' is forecasted at $5.74 billion, suggesting a +0.2% change year-over-year [4] Operating Income Estimates - 'Adjusted operating income (loss)- U.S. Retail Pharmacy' is anticipated to be $113.67 million, down from $501 million year-over-year [5] - 'Adjusted operating income (loss)- International' is expected to be $196.39 million, compared to $175 million from the previous year [5] Stock Performance - Shares of Walgreens have increased by +1.3% over the past month, outperforming the +0.5% move of the Zacks S&P 500 composite [5] - With a Zacks Rank 2 (Buy), WBA is projected to outperform the overall market in the near future [5]